```html

GI Bleed (Gastrointestinal Bleeding) – A Patient‑Friendly Guide

Overview

Gastrointestinal (GI) bleeding refers to any form of bleeding that occurs anywhere along the digestive tract, from the mouth to the anus. It can be classified as:

• Upper GI bleed – originates above the ligament of Treitz (esophagus, stomach, or duodenum).
• Lower GI bleed – originates below the ligament of Treitz (small intestine beyond the duodenum, colon, rectum, or anus).

Both men and women can experience a GI bleed, though the epidemiology varies by cause. In the United States, roughly 1–2 % of the adult population will experience a clinically significant GI bleed each year, accounting for over 300,000 hospital admissions annually. The median age is 65 years, but bleeding can occur at any age, especially in patients with underlying conditions such as peptic ulcer disease, liver cirrhosis, or inflammatory bowel disease.

Symptoms

Symptoms differ depending on the location and rate of bleeding. Below is a complete list with brief explanations.

Upper GI Bleeding

• Hematemesis – vomiting of bright red blood or “coffee‑ground” material (partially digested blood).
• Melena – black, tarry stools indicating that blood has been digested; often suggests bleeding above the ligament of Treitz.
• Bright red (hematochezia) stool – may occur if the bleed is brisk or if the blood moves quickly through the intestine.
• Epigastric pain or burning – commonly associated with peptic ulcers.
• Nausea or vomiting – may accompany bleeding or be a symptom of the underlying cause.

Lower GI Bleeding

• Hematochezia – fresh red blood on toilet paper, in the toilet bowl, or mixed with stool; typical of colonic or rectal sources.
• Occult blood – invisible to the eye; detected by stool guaiac tests or fecal immunochemical tests (FIT).
• Abdominal cramping – often due to inflammatory bowel disease, diverticulitis, or ischemic colitis.
• Tenesmus – a persistent urge to defecate despite an empty rectum, sometimes with bleeding.

Systemic Signs (any location)

• Dizziness, Light‑headedness or Syncope – from blood loss leading to low blood pressure.
• Fatigue or Weakness – anemia develops over days to weeks.
• Rapid heart rate (tachycardia) – compensatory response to volume loss.
• Pallor – pale skin, especially of the lips and nail beds.
• Shortness of breath – can result from anemia or hypovolemia.

Causes and Risk Factors

Common Causes

• Peptic ulcer disease (PUD) – ulcers in the stomach or duodenum are the leading cause of upper GI bleeding (≈30 %).
• Esophageal varices – dilated veins in patients with liver cirrhosis; high‑mortality source.
• Gastric erosions & gastritis – often medication‑related (NSAIDs, aspirin, steroids).
• Mallory‑Weiss tears – mucosal lacerations after forceful vomiting.
• Diverticulosis – pouches in the colon that can bleed profusely.
• Angiodysplasia – fragile, abnormal blood vessels, especially in the right colon.
• Colorectal cancer & polyps – neoplastic lesions can ulcerate and bleed.
• Inflammatory bowel disease (IBD) – ulcerative colitis and Crohn’s disease cause ulcerations.
• Hemorrhoids & anal fissures – common lower GI sources that usually cause bright red bleeding.

Risk Factors

• Regular use of NSAIDs, aspirin, or anticoagulants (warfarin, direct oral anticoagulants).
• Heavy alcohol consumption (promotes gastritis, varices).
• Chronic H. pylori infection.
• Underlying liver disease or cirrhosis.
• Age > 60 years – mucosal integrity declines, and comorbidities increase.
• Smoking – impairs mucosal healing.
• Genetic or familial conditions (e.g., hereditary hemorrhagic telangiectasia).

Diagnosis

Prompt diagnosis is essential to stop bleeding, replace lost blood, and treat the underlying cause.

Initial Assessment

1. History & Physical Exam – nature of bleeding, medication use, comorbidities, vital signs.
2. Hemodynamic status – assess for shock (low BP, tachycardia, altered mental status).

Laboratory Tests

• Complete blood count (CBC) – hemoglobin/hematocrit to gauge blood loss.
• Basic metabolic panel – evaluates electrolytes and renal function.
• Coagulation profile (PT/INR, aPTT) – crucial if patient is on anticoagulants.
• Blood type & cross‑match – for possible transfusion.
• Stool occult blood test – confirms hidden lower GI bleeding.

Imaging & Endoscopic Studies

• Upper endoscopy (EGD) – first‑line for suspected upper GI bleed; visualizes esophagus, stomach, duodenum, and allows therapeutic intervention.
• Colonoscopy – preferred for lower GI bleeding; can be urgent (within 24 h) if patient is stable.
• Capsule endoscopy – useful for obscure bleeding when EGD and colonoscopy are negative.
• CT angiography – rapid detection of active bleeding >0.5 mL/min; guides interventional radiology.
• Radionuclide (99mTc) scan – detects slower bleeding (0.1 mL/min) and helps localize source.

Risk Stratification

Scoring systems such as the Glasgow–Blatchford Score (GBS) and AIMS65 predict need for intervention, length of stay, and mortality.

Treatment Options

Treatment aims to stabilize the patient, stop the bleeding, and address the underlying disease.

Stabilization & Resuscitation

• Establish two large‑bore IV lines.
• Administer crystalloid fluids (e.g., normal saline) to maintain systolic BP > 90 mmHg.
• Transfuse packed red blood cells if hemoglobin < 7 g/dL (or < 8 g/dL in cardiovascular disease).
• Correct coagulopathy: vitamin K, fresh frozen plasma, or prothrombin complex concentrate for warfarin‑related bleeds; reverse agents for DOACs (idarucizumab for dabigatran, andexanet alfa for factor Xa inhibitors).

Pharmacologic Therapy

• Proton pump inhibitors (PPIs) – high‑dose IV (e.g., omeprazole 80 mg bolus then 8 mg/h) reduce re‑bleeding in ulcer‑related upper GI bleeds.
• Octreotide – IV infusion (50 µg bolus then 50 µg/h) for variceal bleeding; reduces portal pressure.
• Antibiotics – prophylactic ceftriaxone (1 g IV q24 h) for cirrhosis with variceal bleed.
• Tranexamic acid – topical or systemic use in select lower GI bleeds (evidence evolving).

Endoscopic Therapy

Performed during diagnostic endoscopy if an active source is identified.

• Thermal coagulation (heater probe, bipolar cautery).
• Injection therapy – epinephrine 1:10,000 dilution.
• Mechanical devices – endoscopic clips or band ligation (varices).
• Sclerosants – for variceal bleeding (e.g., sodium tetradecyl sulfate).

Radiologic & Surgical Interventions

• Trans‑arterial embolization (TAE) – interventional radiology; occludes bleeding vessel when endoscopy fails.
• Angiographic vasopressin infusion – rarely used now.
• Surgical resection or oversewing – reserved for uncontrolled bleeding or perforation.

Lifestyle & Long‑Term Medication Adjustments

• Discontinue or replace NSAIDs/aspirin with safer alternatives (e.g., acetaminophen) if possible.
• Start a PPI for ulcer prevention if chronic acid suppression is indicated.
• Screen and eradicate Helicobacter pylori infection.
• Manage liver disease (abstinence from alcohol, antiviral therapy for hepatitis).
• Control hypertension and diabetes, which can exacerbate vascular lesions.

Living with GI Bleed (Gastrointestinal Bleeding)

Daily Management Tips

1. Medication review – keep an up‑to‑date list; discuss any over‑the‑counter NSAIDs, herbal supplements, or anticoagulants with your clinician.
2. Adhere to prescribed PPIs or H2 blockers – take them 30 minutes before meals.
3. Follow a gentle diet – avoid spicy, acidic, or very hot foods for a few weeks after an ulcer bleed.
4. Stay hydrated – aims to keep blood volume adequate.
5. Monitor stool color – keep a daily log; report any fresh red blood or black, tarry stools.
6. Routine labs – periodic CBC and iron studies to detect anemia early.
7. Vaccinations – especially for patients with cirrhosis (HAV, HBV, pneumococcal, influenza).
8. Regular follow‑up endoscopy – as recommended (often 8–12 weeks after a treated ulcer bleed).

Psychosocial Support

• Consider joining a support group for chronic GI conditions.
• Seek counseling if anxiety about recurrent bleeding interferes with daily life.

Prevention

• Limit NSAID use – use the lowest effective dose for the shortest time; co‑prescribe a PPI if long‑term use is unavoidable.
• Test and treat H. pylori – eradication reduces ulcer recurrence by up to 80 % (Mayo Clinic).
• Control alcohol intake – ≤ 1 drink/day for women, ≤ 2 drinks/day for men.
• Maintain healthy weight and diet – high‑fiber diet, limited processed foods, adequate calcium and vitamin D.
• Manage chronic diseases – optimal control of diabetes, hypertension, and heart disease.
• Screen for colorectal cancer – colonoscopy every 10 years beginning at age 45 (USPSTF).
• Regular liver monitoring – for patients with viral hepatitis or alcohol‑related disease, to identify portal hypertension early.

Complications

If bleeding is not promptly controlled, several serious complications may arise:

• Hypovolemic shock – life‑threatening drop in blood pressure and organ perfusion.
• Severe anemia – leading to fatigue, cardiac strain, or heart failure exacerbation.
• Acute kidney injury – due to reduced renal perfusion.
• Need for massive transfusion – carries risks of transfusion reactions, volume overload, and infection.
• Re‑bleeding – occurs in 10–20 % of ulcer bleeds within 30 days, especially without acid suppression.
• Perforation – especially with ulcer disease; requires emergent surgery.
• Portal hypertensive gastropathy or variceal rupture – in cirrhosis, associated with a 20 % 6‑month mortality.

When to Seek Emergency Care

---

Sources: Mayo Clinic; Centers for Disease Control and Prevention (CDC); National Institutes of Health (NIH) – National Institute of Diabetes and Digestive and Kidney Diseases; World Health Organization (WHO); Cleveland Clinic; American College of Gastroenterology guidelines; peer‑reviewed articles from The New England Journal of Medicine and Gastroenterology (2022‑2024).

```